Work Here?
Industries
Social Impact
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$54.8M
Headquarters
Cambridge, Massachusetts
Founded
2017
Biobot Analytics specializes in wastewater epidemiology, which involves analyzing sewage to gather important public health data. The company serves various clients, including governments, businesses, universities, and health systems, by providing insights into community health trends such as the presence of high-risk substances and the spread of diseases. Biobot's services include regular reports and real-time data derived from wastewater samples, allowing clients to monitor and respond to health trends effectively. Unlike its competitors, Biobot focuses specifically on wastewater analysis, which has proven particularly useful during health crises like the COVID-19 pandemic. The company's goal is to enhance public health efforts and improve community well-being through actionable insights from wastewater data.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$54.8M
Above
Industry Average
Funded Over
3 Rounds
Medical, dental, & vision insurance
Unlimited PTO
Paid parental leave
401k contribution
Home office stipend
Commuter benefits
Free meals
Biobot Analytics has successfully raised an impressive $30 million in its latest funding round, a significant boost that will propel the company's mission to revolutionize public health monitoring through innovative sewage analysis technology.
Biobot Analytics Launches Unique Nationwide Wastewater Monitoring Program
CAMBRIDGE, Mass., Dec. 21, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, announced that the company has reached full enrollment for a nationwide program sponsored by the National Institute on Drug Abuse (NIDA) to conduct anonymous, population-level wastewater-based monitoring on drugs of use and misuse, and overdose reversal agents. This is the first program of its kind in the United States and follows a design similar to that of successful programs in the European Union and Australia.In less than two months, Biobot recruited 70 wastewater treatment facilities and their associated public health departments into the program, with interest surpassing the program limit. Participants span 43 states, 62 counties representing approximately 35 million Americans, and include a diverse mix of urban and rural communities of varying sizes, ranging from San Diego, CA to Laredo, TX.While few of these communities had previously tested wastewater for high-risk substances, all of them expressed a strong interest in utilizing wastewater data to better understand and prevent substance use disorder and overdose deaths. Throughout this process, Biobot was greeted with high levels of enthusiasm for this program from local officials looking for new and innovative ways to limit the deadly impact of fentanyl and similar substances.In announcing the City of San Francisco's participation in this initiative , Dr. Hillary Kunins, SFDPH Behavioral Director, explained: "We need all the tools available to identify the presence of substances that may be used to halt and reverse this deadly epidemic
Former U.S. National Security Advisor joins Biobot to help grow its national security strategyCAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, today announced that Lieutenant General H.R. McMaster, Former U.S. National Security Advisor, has joined the company's Board of Advisors. Lt
Find jobs on Simplify and start your career today
Industries
Social Impact
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$54.8M
Headquarters
Cambridge, Massachusetts
Founded
2017
Find jobs on Simplify and start your career today